Impact of cardiovascular risk factors on plasma biomarkers in prediction of Alzheimer's and cerebrovascular neuropathology
Understanding how cardiovascular risk factors can modulate plasma biomarkers is important for their interpretation with respect to underlying pathology and their clinical application in screening, diagnosis, and prognosis of neurodegenerative diseases.
Authors
- Clifford R. Jack (ORCID: https://orcid.org/0000-0001-7916-622X)
- Jeremy A. Syrjanen (ORCID: https://orcid.org/0000-0001-5990-8206)
- Nikki H. Stricker (ORCID: https://orcid.org/0000-0001-9034-1252)
- Dennis W. Dickson (ORCID: https://orcid.org/0000-0001-7189-7917)
- Naomi Kouri (ORCID: https://orcid.org/0000-0002-6841-9882)
- Prashanthi Vemuri (ORCID: https://orcid.org/0000-0003-4286-0589)
- Ronald Carl Petersen (ORCID: https://orcid.org/0000-0002-8178-6601)
- Christina M. Moloney (ORCID: https://orcid.org/0000-0002-4258-2294)
- Aivi T. Nguyen (ORCID: https://orcid.org/0000-0003-1809-9451)
- Walter K. Kremers (ORCID: https://orcid.org/0000-0001-5714-3473)
- Baayla D.C. Boon (ORCID: https://orcid.org/0000-0002-4922-3286)
- Camilo Bermudez (ORCID: https://orcid.org/0000-0002-9461-5094)
- Jonathan Graff-Radford
- Darren M. Rothberg
- Robert Ross Reichard (ORCID: https://orcid.org/0000-0003-0842-2462)
- Michelle M. Mielke (ORCID: https://orcid.org/0000-0001-7177-1185)
- David S. Knopman
- Alicia Algeciras-Schimnich
- Melissa E. Murray
Institutions
- Mayo Clinic (US)
- WinnMed (US)
- Mayo Clinic in Arizona (US)
- Mayo Clinic in Florida (US)
- Wake Forest University (US)
Publication Details
- Journal
- The Journal of Prevention of Alzheimer s Disease
- Published
- 2025-06-11
- DOI
- https://doi.org/10.1016/j.tjpad.2025.100224
- Citations
- 6
- Primary Topic
- Dementia and Cognitive Impairment Research
- Type
- article
- Field-Weighted Citation Impact
- 8.83
Funders
- Foundation for the National Institutes of Health
- National Institutes of Health